Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas

Details for Australian Patent Application No. 2003280442 (hide)

Owner Wilex AG

Inventors Ullrich, Stefan; Warnaar, Sven Ole

Agent Davies Collison Cave

Pub. Number AU-B-2003280442

PCT Number PCT/EP2003/0065

PCT Pub. Number WO2004/002526

Priority 60/392,311 01.07.02 US

Filing date 23 June 2003

Wipo publication date 19 January 2004

Acceptance publication date 5 February 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 60/392,311 01.07.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003280442

5 February 2009 Application Accepted

  Published as AU-B-2003280442

4 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003280443-NON-T CELL BINDING PEPTIDES AND THEIR USES

2003280441-Tea manufacture